Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion—a randomized controlled equivalence trial
Author(s) -
Helena Hognert,
Helena Kopp Kallner,
Sharon Cameron,
Christiyrelli,
Izabella Jawad,
Rebecca Heller,
Annette Aronsson,
Ingela Lindh,
Lina Benson,
Kristina GemzellDanielsson
Publication year - 2016
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dew238
Subject(s) - etonogestrel , medicine , contraceptive implant , medical abortion , desogestrel , mifepristone , obstetrics , abortion , randomized controlled trial , gynecology , unintended pregnancy , implant , pregnancy , long acting reversible contraception , population , family planning , surgery , misoprostol , research methodology , environmental health , biology , genetics
Does a progestin releasing subdermal contraceptive implant affect the efficacy of medical abortion if inserted at the same visit as the progesterone receptor modulator, mifepristone, at medical abortion?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom